Evaluation of biomarkers indicating fibrotic activity in idiopathic pulmonary fibrosis and other diffuse parenchymal lung diseases.

Recruiting

• Conditions: J84; J43; Other interstitial pulmonary diseases; Emphysema

• Registration Number: DRKS00000017
• Lead Sponsor: Abteilung für Pneumologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Patients with IPF, COPD, Bronchiolitis obliterans Syndrome, Patients with other ILDs, Healthy Volunteers

Exclusion Criteria

known tumor disease
known aktive infection

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival, Change in FVC percent predicted (> 10%), Change in TLC percent predicted (> 10%),

Secondary Outcome Measures

Name	Time	Method
Changes in 6 min shuttle walk test, DLCO.